Wells Fargo’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-472,164
Closed -$42.1M 6670
2017
Q1
$42.1M Sell
472,164
-297,070
-39% -$24.4M 0.01% 937
2016
Q4
$54.4M Sell
769,234
-31,038
-4% -$2.31M 0.02% 792
2016
Q3
$63.2M Buy
800,272
+45,372
+6% +$3.87M 0.02% 676
2016
Q2
$68.5M Buy
754,900
+32,269
+4% +$2.73M 0.03% 617
2016
Q1
$61.4M Sell
722,631
-55,861
-7% -$4.16M 0.02% 649
2015
Q4
$61.5M Buy
778,492
+4,269
+0.6% +$336K 0.02% 661
2015
Q3
$54.5M Buy
774,223
+120,708
+18% +$9.93M 0.02% 704
2015
Q2
$59M Sell
653,515
-25,351
-4% -$2.44M 0.02% 727
2015
Q1
$68.2M Sell
678,866
-22,458
-3% -$2.26M 0.03% 641
2014
Q4
$70.5M Buy
701,324
+18,108
+3% +$1.8M 0.03% 604
2014
Q3
$65.7M Sell
683,216
-30,716
-4% -$2.91M 0.03% 620
2014
Q2
$66.5M Buy
713,932
+6,817
+1% +$596K 0.03% 644
2014
Q1
$58.8M Buy
707,115
+10,545
+2% +$855K 0.03% 680
2013
Q4
$58.3M Buy
696,570
+22,834
+3% +$1.86M 0.03% 673
2013
Q3
$50M Buy
673,736
+20,246
+3% +$1.52M 0.02% 689
2013
Q2
$51.8M Buy
+653,490
New +$52.4M 0.03% 618

Other funds holding MJN

Wells Fargo's MJN Position: Q2 2017 in Review

Wells Fargo sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 472,164 shares — an estimated $42.1M sold.

Wells Fargo first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $70.5M in Q4 2014. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Wells Fargo reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Wells Fargo sold 472,164 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $42.1M.
  • Wells Fargo first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Wells Fargo's Mead Johnson Nutrition Company position peaked at $70.5M in Q4 2014.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Wells Fargo's 13F filing for Q2 2017, filed 10 Aug 2017.